Company
Ocutx
Ocular Therapeutix - Transforming Retinal Disease Treatment with AXPAXLI™
- Business model
- B2B
Record updated 28 September 2026
About
Discover Ocular Therapeutix's retinal disease treatments. Learn more about AXPAXLI, our potential treatment for wet AMD our sustained-release hydrogel therapy, is redefining outcomes for wet AMD.